What changed in this filing

/stocks — the workspaceLOADING

Item 9A. Controls and Procedures

2025-04-01 compared with 2024-04-01 · 184 added, 123 removed, 25 unchanged (92% of the section changed)

CONTROLS AND PROCEDURES.

Disclosure Control and Procedures

We maintain disclosure controls and procedures (as such terms are defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that the information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Interim Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Management, under the supervision and with the participation of our Chief Executive Officer and Principal Financial Officer evaluated the effectiveness and design of our disclosure controls and procedures pursuant to Exchange Act Rule 13a-15(b) as of December 31, 2023.

Based on that evaluation, our Chief Executive Officer and Interim Chief Financial Officer concluded that these disclosure controls and procedures were effective as of December 31, 2023.

Management ’ s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f) promulgated under the Exchange Act).

Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of our financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.

Internal control over financial reporting includes those policies and procedures that:

(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect our transactions and dispositions of our assets;

(ii) provide reasonable assurance that transactions are recorded as necessary for preparation of our financial statements in accordance with generally accepted accounting principles;

(iii) provide reasonable assurance that our receipts and expenditures are made in accordance with management authorization;

and (iv) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting, however well designed and operated can provide only reasonable, and not absolute, assurance that the controls will prevent or detect misstatements.

In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events.

Because of these and other inherent limitations of control systems, there is only the reasonable assurance that our controls will succeed in achieving their goals under all potential future conditions.

Management, under the supervision and with the participation of our Chief Executive Officer and Interim Chief Financial Officer, conducted an evaluation of our internal control over financial reporting as of December 31, 2023, based on the framework in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

Based on our evaluation under the COSO framework, management concluded that our internal control over financial reporting was effective as of December 31, 2023.

There have been no changes in our internal control over financial reporting during the quarter ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

This Report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting.

Additionally, management’s report was not subject to attestation by our registered public accounting firm pursuant to the permanent exemption from Section 404(b) of the Sarbanes-Oxley Act of 2002 for non-accelerated filers.

OTHER INFORMATION

During the three months ended December 31, 2023, none of our directors or executive officers adopted, modified or terminated a “Rule 10b5 - 1 trading arrangement” or a “non-Rule 10b5 - 1 trading arrangement” as such terms are defined under Item 408 of Regulation S-K.

DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not applicable.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

Information regarding our Code of Ethics is included in Item 1 of Part I, and that information is incorporated by reference herein.

The other information called for by Part III, Item 10, will be included in our proxy statement relating to our 2024 Annual Meeting of Shareholders (our “2024 Proxy Statement”), and is incorporated herein by reference to the sections captioned “Nominees,” “Compliance with Section 16(a),” “Board Meetings and Committees,” “Audit Committee,” “Director Nomination Process,” and “Executive Officers.” Our 2024 Proxy Statement will be filed within 120 days of December 31, 2023, our fiscal year end.

EXECUTIVE COMPENSATION.

Information called for by Part III, Item 11, will be included in our 2024 Proxy Statement, and is incorporated herein by reference to the sections captioned “Executive Compensation” and “Director Compensation.” Our 2024 Proxy Statement will be filed within 120 days of December 31, 2023, our fiscal year end.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS.

Certain information called for by Part III, Item 12, will be included in our 2024 Proxy Statement, and is incorporated herein by reference to the section captioned “Security Ownership of Certain Beneficial Owners And Management.” Our 2024 Proxy Statement will be filed within 120 days of December 31, 2023, our fiscal year end.

Equity Compensation Plan Information

The following table gives information as of December 31, 2023, the end of the most recently completed fiscal year, about shares of common stock that may be issued pursuant to currently outstanding stock options granted under Jones Soda Co.

2011 Incentive Plan, as well as shares of common stock issuable pursuant to awards granted under the Jones Soda Co.

AND PROCEDURES.

Control and Procedures

maintain disclosure controls and procedures (as such terms are defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange

Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that the information required to be disclosed in

the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified

in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief

Executive Officer and Interim Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

under the supervision and with the participation of our Chief Executive Officer and Principal Financial Officer evaluated the effectiveness

and design of our disclosure controls and procedures pursuant to Exchange Act Rule 13a-15(b) as of December 31, 2024.

Based on that evaluation,

our Chief Executive Officer and Interim Chief Financial Officer concluded that these disclosure controls and procedures were effective

as of December 31, 2024.

Management ’ s

Report on Internal Control Over Financial Reporting

management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Exchange

Act Rule 13a-15(f) and 15d-15(f) promulgated under the Exchange Act).

Internal control over financial reporting is a process designed

to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of our financial statements

for external purposes in accordance with accounting principles generally accepted in the United States of America.

Internal control over

financial reporting includes those policies and procedures that:

(i) pertain to the maintenance of records that, in reasonable detail,

accurately and fairly reflect our transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions

are recorded as necessary for preparation of our financial statements in accordance with generally accepted accounting principles;

(iii) provide reasonable assurance that our receipts and expenditures are made in accordance with management authorization; and

(iv) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets

that could have a material effect on the financial statements.

of its inherent limitations, internal control over financial reporting, however well designed and operated can provide only reasonable,

and not absolute, assurance that the controls will prevent or detect misstatements.

In addition, the design of any control system is

based in part upon certain assumptions about the likelihood of future events.

Because of these and other inherent limitations of control

systems, there is only the reasonable assurance that our controls will succeed in achieving their goals under all potential future conditions.

under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation

of our internal control over financial reporting as of December 31, 2024, based on the framework in Internal Control-Integrated Framework

(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

Based on our evaluation under the COSO

framework, management concluded that , as of such date, our internal controls over financial reporting were not effective as of

the end of the period covered by this Annual Report on Form 10-K due to material weaknesses as describe herein.

A material weakness is

a control deficiency (within the meaning of the Public Company Accounting Oversight Board (United States) Auditing Standard No.

combination of control deficiencies that result in more than a remote likelihood that a material misstatement of the annual or interim

financial statements will not be prevented or detected.

Management has identified the following material weaknesses:

The Company had key senior accounting personnel transitioned over the course of the year-end process from the end of 2024 through

the beginning of 2025.

As a result, adjustments to the year end balances were required to be made.

During the transition period noted above the Company lacked sufficient resources with respect to the number of people employed in

its accounting department and the adequacy of their training in relation to its financial reporting requirements.

The Company announced a new experienced CFO in February, 2025.

The Company hired additional CPA consultants to complete the year end

Company is now through that transition and the new leadership team will ensure previously effective controls are followed by the time

we report the second quarter interim results and reinforced adherence to the set of internal controls that Company has previously successfully

abided by over the past years.

Report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting.

Additionally, management’s report was not subject to attestation by our registered public accounting firm pursuant to the permanent

exemption from Section 404(b) of the Sarbanes- Oxley Act of 2002 for non-accelerated filers.

the three months ended December 31, 2024, none of our directors or executive officers adopted , modified or terminated a “Rule 10b5-1

trading arrangement” or a “non-Rule 10b5-1 trading arrangement” as such terms are defined under Item 408 of Regulation

REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

regarding our Code of Ethics is included in Item 1 of Part I, and that information is incorporated by reference herein.

other information called for by Part III, Item 10, will be included in our proxy statement relating to our 2024 Annual Meeting of Shareholders

(our “2024 Proxy Statement”), and is incorporated herein by reference to the sections captioned “Nominees,” “Compliance

with Section 16(a),” “Board Meetings and Committees,” “Audit Committee,” “Director Nomination Process,”

and “Executive Officers.” Our 2025 Proxy Statement is expected to be filed within 120 days of December 31, 2024, our fiscal

COMPENSATION.

called for by Part III, Item 11, will be included in our 2025 Proxy Statement, and is incorporated herein by reference to the sections

captioned “Executive Compensation” and “Director Compensation.” Our 2025 Proxy Statement is expected to be filed

within 120 days of December 31, 2024, our fiscal year end.

OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS.

information called for by Part III, Item 12, will be included in our 2024 Proxy Statement, and is incorporated herein by reference to

the section captioned “Security Ownership of Certain Beneficial Owners And Management.” Our 2025 Proxy Statement is expected

to be filed within 120 days of December 31, 2024, our fiscal year end.

Compensation Plan Information

following table gives information as of December 31, 2024, the end of the most recently completed fiscal year, about shares of common

stock that may be issued pursuant to currently outstanding stock options granted under Jones Soda Co.

2011 Incentive Plan, as well as

shares of common stock issuable pursuant to awards granted under the Jones Soda Co.

2022 Omnibus Equity Incentive Plan.

Plan Category

of Shares to be

Issued Upon Exercise

or Vesting of

Outstanding Stock

Options, RSUs

(b) Weighted Average

Exercise Price of

Outstanding Stock

Options, Warrants and

Securities Remaining

Available for Future

Issuance Under Equity

Compensation Plans

(Excluding Securities

of Shares to be Issued Upon Exercise or Vesting of Outstanding Stock Options, RSUs

(b) Weighted Average Exercise Price of Outstanding Stock Options, Warrants and Rights

(c) Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities (a) )

Equity Compensation Plans Approved by Shareholders

Equity Compensation Plans Not Approved by Shareholders

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Information called for by Part III, Item 13, will be included in our 2024 Proxy Statement, and is incorporated herein by reference to the sections captioned “Transactions with Related Persons” and “Independence of Board of Directors.” Our 2024 Proxy Statement will be filed within 120 days of December 31, 2023, our fiscal year end.

PRINCIPAL ACCOUNTING FEES AND SERVICES.

Information called for by Part III, Item 14, will be included in our 2024 Proxy Statement, and is incorporated herein by reference to the sections captioned “Policy for Approval of Audit and Permitted Non-Audit Services” and “Audit and Audit-Related Fees.” Our 2024 Proxy Statement will be filed within 120 days of December 31, 2023, our fiscal year end.

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

(a) Documents filed as part of this Report are as follows:

Financial Statements:

The consolidated financial statements, related notes and report of independent registered public accounting firm are included in Item 8 of Part II of this Report.

Financial Statement Schedules:

All schedules have been omitted because they are not applicable or not required, or the required information is included in the financial statements or notes thereto.

The required exhibits are included at the end of this Report and are described in the exhibit index.

Not applicable.

EXHIBIT INDEX

The following exhibits are filed as part of this Annual Report on Form 10-K or are incorporated herein by reference.

Where an exhibit is incorporated by reference, the document to which it is cross referenced is made.

Articles of Incorporation of Jones Soda Co.

(Previously filed as, and incorporated herein by reference to, Exhibit 3.1 to our annual report on Form 10-KSB for the fiscal year ended December 31, 2000, filed on March 30, 2001;

Amended and Restated Bylaws of Jones Soda Co.

(Previously filed with, and incorporated herein by reference to, Exhibit 3.1 to our quarterly report on Form 10-Q, filed on November 8, 2013;

Articles of Amendment to Articles of Incorporation of Jones Soda Co.

RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

called for by Part III, Item 13, will be included in our 2025 Proxy Statement, and is incorporated herein by reference to the sections

captioned “Transactions with Related Persons” and “Independence of Board of Directors.” Our 2025 Proxy Statement

is expected to be filed within 120 days of December 31, 2024, our fiscal year end.

ACCOUNTING FEES AND SERVICES.

called for by Part III, Item 14, will be included in our 2025 Proxy Statement, and is incorporated herein by reference to the sections

captioned “Policy for Approval of Audit and Permitted Non-Audit Services” and “Audit and Audit-Related Fees.”

Our 2025 Proxy Statement is expected to be filed within 120 days of December 31, 2024, our fiscal year end.

AND FINANCIAL STATEMENT SCHEDULES.

(a) Documents

filed as part of this Report are as follows:

The consolidated financial statements, related notes and report of independent

registered public accounting firm are included in Item 8 of Part II of this Report.

Statement Schedules:

All schedules have been omitted because they are not applicable or not

required, or the required information is included in the financial statements or notes thereto.

The required exhibits are included at the end of this Report and are described in the exhibit

following exhibits are filed as part of this Annual Report on Form 10-K or are incorporated herein by reference.

Where an exhibit is

incorporated by reference, the document to which it is cross referenced is made.

of Incorporation of Jones Soda Co.

(Previously filed as, and incorporated herein by reference to, Exhibit 3.1 to our annual report

on Form 10-KSB for the fiscal year ended December 31, 2000, filed on March 30, 2001; File No.

and Restated Bylaws of Jones Soda Co.

(Previously filed with, and incorporated herein by reference to, Exhibit 3.1 to our quarterly

report on Form 10-Q, filed on November 8, 2013; File No.

of Amendment to Articles of Incorporation of Jones Soda Co.

dated May 16, 2022.

(Previously filed with, and incorporated herein by reference to, Exhibit 3.3 to our registration statement on Form S-1, filed on June 14, 2022;

(Previously filed with, and incorporated herein by

reference to, Exhibit 3.3 to our registration statement on Form S-1, filed on June 14, 2022; File No.

Description of Registrant’s Securities (Filed herewith).

Form of Registration Rights Agreement (Previously filed with, and incorporated herein by reference to, Exhibit 10.3 to our current report on Form 8-K, filed on March 27, 2018;

Registration Rights Agreement dated July 14, 2021 between Jones Soda Co.

and SOL Verano Blocker 1 LLC (Previously filed with, and incorporated herein by reference to, Exhibit 10.2 to our Current Report on Form 8-K, filed on July 20, 2021;

Registration Rights Agreement dated February 9, 2022 between Jones Soda Co.

and the holders of the Contingent Convertible Debentures (Previously filed with, and incorporated herein by reference to, Exhibit 10.2 to our Current Report on Form 8-K, filed on February 15, 2022;

Recission Agreement dated December 30, 2022, between Jones Soda Co.

and Mark Murray (Previously filed with, and incorporated herein by reference to, Exhibit 10.1 to our current report on Form 8-K, filed on January 6, 2023;

Release of Claims Agreement dated June 8, 2023, between the Company and Mark Murray (Previously filed with, and incorporated herein by reference to, Exhibit 10.1 to our current report on Form 8-K, filed on June 13, 2023;

Employment Agreement dated June 8, 2023, between the Company and David Knight (Previously filed with, and incorporated herein by reference to, Exhibit 10.2 to our current report on Form 8-K, filed on June 13, 2023;

Jones Soda Co.

of Registration Rights Agreement (Previously filed with, and incorporated herein by reference to, Exhibit 10.3 to our current report

on Form 8-K, filed on March 27, 2018; File No.

Rights Agreement dated July 14, 2021 between Jones Soda Co.

and SOL Verano Blocker 1 LLC (Previously filed with, and incorporated

herein by reference to, Exhibit 10.2 to our Current Report on Form 8-K, filed on July 20, 2021; File No.

Rights Agreement dated February 9, 2022 between Jones Soda Co.

and the holders of the Contingent Convertible Debentures (Previously

filed with, and incorporated herein by reference to, Exhibit 10.2 to our Current Report on Form 8-K, filed on February 15, 2022;

Form of Registration Rights Agreement (Previously filed with, and incorporated herein by reference to, Exhibit 10.1 to our Current Report on Form 8-K, filed on August 1, 2024; File No.

Form of Non-Transferable Warrant to Purchase Common Shares of Jones Soda Co.

(Previously filed with, and incorporated herein by reference to, Exhibit 4.1 to our Current Report on Form 8-K, filed on August 1, 2024; File No.

Agreement dated December 30, 2022, between Jones Soda Co.

and Mark Murray (Previously filed with, and incorporated herein by reference

to, Exhibit 10.1 to our current report on Form 8-K, filed on January 6, 2023; File No.

of Claims Agreement dated June 8, 2023, between the Company and Mark Murray (Previously filed with, and incorporated herein by reference

to, Exhibit 10.1 to our current report on Form 8-K, filed on June 13, 2023; File No.

Agreement dated February 5, 2025, between the Company and Scott Harvey (Previously filed with, and incorporated herein by reference

to, Exhibit 10.1 to our current report on Form 8-K, filed on February 13, 2025; File No.

Agreement dated February 12, 2025, between the Company and Brian Meadows (Previously filed with, and incorporated herein by reference

to, Exhibit 10.2 to our current report on Form 8-K, filed on February 13, 2025; File No.

2011 Incentive Plan.

(Previously filed with, and incorporated herein by reference to, Annex A to our Definitive Proxy Statement on Schedule 14A, filed on April 12, 2011, File No.

Jones Soda Co.

2022 Omnibus Equity Incentive Plan (Previously filed with, and incorporated herein by reference to, Annex B to our Definitive Proxy Statement on Schedule 14A, filed on April 1, 2022, File No.

(Previously filed with, and incorporated herein by reference to, Annex A to our Definitive Proxy Statement

on Schedule 14A, filed on April 12, 2011, File No.

2022 Omnibus Equity Incentive Plan (Previously filed with, and incorporated herein by reference to, Annex B to our Definitive

Proxy Statement on Schedule 14A, filed on April 1, 2022, File No.

Form of Restricted Stock Unit Award Agreement under the Jones Soda Co.

2022 Omnibus Equity Incentive Plan (Filed herewith).

2022 Omnibus Equity Incentive Plan (Previously filed with, and incorporated herein by reference to Exhibit 10.7 on our Annual Report on Form 10-K, filed on April 1, 2024, File No.

Form of Stock Option Award Agreement under the Jones Soda Co.

2022 Omnibus Equity Incentive Plan (Filed herewith).

Employment Offer Letter dated February 27, 2024, between Jones Soda Co.

Bittner (Filed herewith).

2022 Omnibus Equity Incentive Plan (Previously filed with, and incorporated herein by reference to Exhibit 10.8 on our Annual Report on Form 10-K, filed on April 1, 2024, File No.

Employment Agreement dated October 23, 2023, between Jones Soda Co.

and Jerry Goldner (Filed herewith).

Letter from Armanino LLP (Previously filed with, and incorporated herein by reference to, Exhibit 16.1 to our current report on Form 8-K, filed on July 18, 2023;

and Jerry Goldner (Previously filed with, and incorporated herein by reference to Exhibit 10.9 on our Annual Report on Form 10-K, filed on April 1, 2024, File No.

Financing and Assignment Agreement dated May 17, 2024 between Jones Soda Co.

and Amerisource Funding Inc.

Employment Agreement

dated February 5, 2025, between the Company and Scott Harvey (Previously filed with, and incorporated herein by reference to, Exhibit

10.1 to our quarterly report on Form 10-Q, filed on August 14, 2024; File No.

from Armanino LLP (Previously filed with, and incorporated herein by reference to, Exhibit 16.1 to our current report on Form 8-K,

filed on July 18, 2023; File No.

Subsidiaries of the Registrant (Filed herewith).

Consent of Berkowitz, Pollack Brant Advisors + CPAs (Filed herewith).

Consent of Armanino LLP (Filed herewith).

Certification by David Knight, Chief Executive Officer, pursuant to Rule 13a-14(a), pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Filed herewith).

Certification by Joe Culp, Interim Chief Financial Officer, pursuant to Rule 13a-14(a), pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Filed herewith).

Certification by David Knight, Chief Executive Officer, pursuant to 18 U.S.C.

Certification by Scott Harvey, Chief Executive Officer, pursuant to Rule 13a-14(a), pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Filed herewith).

Certification by Brian Meadows, Chief Financial Officer, pursuant to Rule 13a-14(a), pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Filed herewith).

Certification by Scott Harvey, Chief Executive Officer, pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Filed herewith).

Certification by Joe Culp, Interim Chief Financial Officer, pursuant to 18 U.S.C.

Certification by Brian Meadows, Chief Financial Officer, pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Filed herewith).

Inline XBRL Instance Document.

Inline XBRL Taxonomy Extension Schema Document.

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

Inline XBRL Taxonomy Extension Definition Linkbase Document.

Inline XBRL Taxonomy Extension Label Linkbase Document.

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

XBRL Instance Document.

XBRL Taxonomy Extension Schema Document.

XBRL Taxonomy Extension Calculation Linkbase Document.

XBRL Taxonomy Extension Definition Linkbase Document.

XBRL Taxonomy Extension Label Linkbase Document.

XBRL Taxonomy Extension Presentation Linkbase Document.

Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Management contract or compensatory plan or arrangement.

Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability.

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

April 1, 2024

Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus

for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are

not subject to liability.

to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed

on its behalf by the undersigned, thereunto duly authorized.

March 31, 2025

JONES SODA CO.

Director of Finance, Principal

Financial Officer, and Interim Chief

Financial Officer

POWER OF ATTORNEY

Each person whose individual signature appears below hereby authorizes and appoints David Knight and Paul Norman and each of them, with full power of substitution and resubstitution and full power to act without the other, as his true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file, any and all amendments to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his or her substitute or substitutes may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

/s/ DAVID KNIGHT

/s/ Brian Meadows

Chief Financial Officer

person whose individual signature appears below hereby authorizes and appoints Scott Harvey and Brian Meadows and each of them, with

full power of substitution and resubstitution and full power to act without the other, as his true and lawful attorney-in-fact and agent

to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity

stated below, and to file, any and all amendments to this report, and to file the same, with all exhibits thereto, and other documents

in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in fact and agents, and each of them,

full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and

agents or any of them or their or his or her substitute or substitutes may lawfully do or cause to be done by virtue thereof.

to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the

registrant and in the capacities and on the dates indicated.

/s/ SCOTT HARVEY

President and Chief Executive Officer (Principal Executive Officer)

April 1, 2024

Interim Chief Financial Officer ( Principal Financial Officer and Principal Accounting Officer)

April 1, 2024

March 31, 2025

/s/ BRIAN MEADOWS

Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

March 31, 2025

Brian Meadows

/s/RONALD DISSINGER

April 1, 2024

March 31, 2025

Ronald Dissinger

/s/ CHAD BRONSTEIN

April 1, 2024

Chad Bronstein

/s/ PAUL NORMAN

Chairman of the Board, Director

April 1, 2024

March 31, 2025

/s/ CLIVE SIRKIN

April 1, 2024

March 31, 2025

/s/ GREGG REICHMAN

April 1, 2024

March 31, 2025

Gregg Reichman

/s/ MARK MURRAY

April 1, 2024

March 31, 2025

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 9A. Controls and Procedures